The landscape of dementia diagnosis has progressed dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based checks that could detect Alzheimer's pathology a long time before indications emerge. While these technological advancements signify remarkable progress in understanding neurodegenerative disorders, they'... https://douglast763rbk2.blognody.com/profile